Vincera Pharma Inc (VINC)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.6480 +0.0280 (+4.52%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.6230 -0.0250 (-3.86%) 18:47 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,854 | 11,733 | 111,564 | 61,792 | N/A |
| Marketable Securities | N/A | 40,796 | N/A | N/A | N/A |
| Receivables | 1,044 | 1,372 | N/A | N/A | N/A |
| Other current assets | 784 | 1,929 | 95 | 214 | 0 |
| TOTAL | $14,733 | $55,964 | $111,841 | $63,110 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 125 | 177 | 233 | N/A | N/A |
| Other Non-Current Assets | 3,359 | 3,145 | 5,602 | 82 | 0 |
| TOTAL | $3,484 | $3,322 | $5,835 | $82 | $N/A |
| Total Assets | $18,217 | $59,286 | $117,676 | $63,192 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,497 | 4,065 | 2,019 | 5,505 | 44 |
| Accrued Expenses | 1,755 | 3,923 | 4,715 | N/A | N/A |
| Other current liabilities | 191 | 144 | 6,447 | 32,308 | N/A |
| TOTAL | $5,605 | $9,156 | $13,919 | $37,813 | $44 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 1,390 | 2,462 | 3,436 | 0 | 0 |
| TOTAL | $1,390 | $2,462 | $3,436 | $N/A | $N/A |
| Total Liabilities | $6,995 | $11,618 | $17,355 | $37,813 | $44 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,071 | 1,062 | 1,053 | 699 | N/A |
| Common Shares | 2 | 2 | 2 | 1 | 1 |
| Retained earnings | -159,112 | -118,955 | -55,971 | -16,665 | -45 |
| Other shareholders' equity | 8 | -26 | -21 | 0 | -1 |
| TOTAL | $11,222 | $47,668 | $100,321 | $25,379 | $-44 |
| Total Liabilities And Equity | $18,217 | $59,286 | $117,676 | $63,192 | $0 |